Edition:
United Kingdom

People: Smith & Nephew PLC (SN.L)

SN.L on London Stock Exchange

1,684.00GBp
26 Jun 2019
Change (% chg)

-24.00 (-1.41%)
Prev Close
1,708.00
Open
1,710.00
Day's High
1,710.50
Day's Low
1,678.50
Volume
1,622,729
Avg. Vol
2,058,752
52-wk High
1,738.50
52-wk Low
1,242.50

Diggelmann, Roland 

Mr. Roland Diggelmann is Non-Executive Independent Director of the Company since 1 March 2018. He was elected by shareholders at the AGM on 12 April 2018. He will join the Compliance & Culture Committee in April 2019. Career and experience Roland studied Business Administration at the University of Berne. In 1995, he joined Sulzer AG as Manager Strategic Planning and progressed into further senior roles over the years until his appointment as Executive Vice President, Sales Europe and Asia Pacific from 2002 to 2004 for Sulzer Medica (later known as Centerpulse). Roland joined Zimmer Group in 2004, in the role of Managing Director of Zimmer Japan and then later in 2006 as Senior Vice President, EMEA until 2008. Roland joined Roche Diagnostics in 2008 starting as president of Asia Pacific before assuming the role of Chief Executive Officer of the Diagnostics Division of F. Hoffmann-La Roche Ltd from 2012 until September 2018. Skills and competencies Having spent his whole career in medical devices, with 12 years at Sulzer and Zimmer, Roland brings an in-depth knowledge of the medical device industry and healthcare environment which is of great value to Smith & Nephew.

Basic Compensation

Total Annual Compensation, GBP 59,000
Restricted Stock Award, GBP --
Long-Term Incentive Plans, GBP --
All Other, GBP --
Fiscal Year Total, GBP 59,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --